Regenicin (RGIN) Stock Statistics & Valuation Metrics

Regenicin has a market cap or net worth of $15.35K. The enterprise value is $643.70K.

Regenicin has 153,483,050 shares outstanding. The number of shares has decreased by -2.65% in one year.

Regenicin’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 12.13%.

The current PE Ratio of Regenicin is ―. Regenicin’s PEG ratio is 0.12.

In the last 12 months, Regenicin had revenue of 0.00 and earned -639.00K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -700.22K and capital expenditures 0.00, giving a free cash flow of -700.22K billion.

Regenicin pays an annual dividend of ―, resulting in a dividend yield of ―

Regenicin upcoming earnings date is Feb 20, 2018, During Market Hours (Confirmed).

Regenicin as a current ratio of <0.01, with Debt / Equity ratio of -11.49%

In the past 12 months, Regenicin has paid 0.00 in taxes.

Regenicin EV to EBITDA ratio is -1.86, with an EV/FCF ratio of -41.02.

Regenicin has $11.86M in cash and marketable securities with $642.92K in debt, giving a net cash position of $11.22M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Regenicin is ―, which is 11.43% higher than the current price. The consensus rating is ―